GENE ONLINE|News &
Opinion
Blog

ATTR amyloidosis
Trials & Approvals Amyloidosis
AstraZeneca, Ionis’ ATTR Drug Edges Closer to US Approval With Latest Trial Win
2022-06-22
Trials & Approvals RNAi Therapeutics
FDA Approves Alnylam’s Rare Disease RNAi Therapeutic
2022-06-15
Deals ATTR amyloidosis
AstraZeneca, Ionis Close $3.5+ Billion Deal for Rare Protein Misfolding Disorder
2021-12-30
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
LATEST
Crossing Borders for a New Era in Medical Service Standards: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top